Greenlane Holdings, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; financial figures below are in thousands of dollars unless stated otherwise. The report was signed and filed July 24, 2024. Greenlane distributes cannabis accessories, packaging, vaporization products, and lifestyle goods through Consumer Goods and Industrial Goods segments.
Financial performance and position
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net sales | $4,926 | $23,959 |
| Gross profit / gross margin | $1,512 / 30.7% | $5,519 / 23.0% |
| Operating loss | $(3,980) | $(8,019) |
| Net loss | $(4,491) | $(8,747) |
| Net loss per share, basic and diluted | $(0.85) | $(5.44) |
| Cash used in operating activities | $(81) | Cash provided: $1,883 |
- Sales fell 79.4% year over year. Consumer Goods revenue decreased 70.9% to $2,274; Industrial Goods fell 83.6% to $2,652.
- Gross margin improved to 30.7% from 23.0%, while gross profit declined with lower sales. Management attributed the margin improvement partly to the shift toward commission-based sales and lower inventory write-offs.
- Operating expenses declined 59.4% to $5,492, including salaries and benefits down 45.1% and general and administrative expenses down 70.1%, reflecting restructuring and cost reductions.
- At March 31, cash was $157; current assets were $26,934 and current liabilities $27,692, implying negative working capital of approximately $758. Total assets were $35,063, total liabilities $28,474, and stockholders’ equity $6,589.
- Debt of $7,202 was all classified as current: $2,093 of future-receivables financing and $5,109 under the secured bridge loan. The debt maturities table places the full amount in the remainder of 2024.
- Cash declined by $306 during the quarter. Investing activities used $135; financing activities used $92. Inventory fell by $2,210 during the quarter.
Material changes and management commentary
- Management said the sharp sales decline reflected restructuring, rationalization of lower-margin third-party products, stock-outs caused in part by limited access to capital, and conversion of much of Industrial Goods activity from gross sales to net commission revenue. The company is prioritizing profitable revenue and lower working-capital needs over top-line sales.
- Management reported weaker-than-planned demand and stated cash and operating cash flows were not expected to cover working capital, capital expenditures, debt repayments, and other needs for the next 12 months. It warned that available funds may be insufficient to fund planned operations into the third quarter of 2024. The filing states that substantial doubt exists about the company’s ability to continue as a going concern.
- Plans to address liquidity and profitability include further cost reductions, new products and customer acquisition, margin-accretive partnerships, and seeking debt or equity capital. Management cautioned that there is no assurance these measures will succeed. The ATM program and shelf registration were unavailable for further use because of untimely SEC filings.
- In May 2024, Synergy Imports purchased specified Eyce and DaVinci-related intellectual property, inventory, and other assets under an agreement accompanied by a loan modification; the amended note maturity was extended through July 2024.
- From April 1 through July 24, 2024, Greenlane issued 1,497,000 Class A shares upon exercise of remaining penny warrants. The board also proposed authorization for a possible 1-for-2 to 1-for-20 reverse split. A planned sale of Shavita B.V. and substantially all ARI Logistics B.V. assets had not closed as of the financial statements’ issuance date.
Risks, contingencies, and controls
- Going concern and financing: Limited cash, negative working capital, losses, near-term debt maturities, and inability to use the shelf/ATM raise substantial liquidity risk. The filing notes that failure to secure funding or improve operations could require asset sales, reduced or delayed activities, other strategic alternatives, or potentially insolvency proceedings.
- Nasdaq: The company had an additional compliance period through August 19, 2024 to regain the minimum bid-price requirement, potentially through a reverse split. It also disclosed noncompliance with board independence and audit committee requirements following a director’s resignation, and prior noncompliance related to late periodic reports. The filing states the 10-K and 10-Q were filed within the additional time granted.
- Internal controls: Management concluded disclosure controls were not effective as of March 31, 2024 because previously reported material weaknesses in internal control over financial reporting remained unremediated.
- Contingencies and concentration: The company disclosed potential VAT and other non-income tax exposures. It recorded approximately $442 of VAT payable, including amounts related to the European VAT matter. One customer represented 28% of Q1 sales and 24% of accounts receivable at quarter-end.
- The company reported no litigation reserves and said it did not believe pending legal proceedings would have a material adverse effect, while acknowledging that outcomes are uncertain.
- No specific revenue or earnings guidance was provided.
Most important facts for investors to verify
- Near-term cash runway, available financing, and ability to meet the $7.2 million current debt balance and other obligations.
- Whether the planned cost reductions, partnerships, inventory actions, and product strategy can stabilize revenue and produce sustainable positive operating cash flow.
- How much of the sales decline reflects discontinued or restructured activity and net commission presentation versus underlying demand weakness.
- Progress on Nasdaq bid-price, governance, and filing compliance, including any reverse split and its effect on shareholders.
- Status and financial impact of the Eyce/DaVinci asset transaction and loan modification, the proposed subsidiary sale, and post-quarter warrant exercises.
- Remediation of material weaknesses and potential exposure from VAT and other tax matters.